On August 3, 2026, Danaher's Board of Directors appointed Julie Sawyer Montgomery President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026, succeeding Rainer M. Blair. She currently serves as Executive Vice President of Danaher, with responsibility for the Diagnostics platform.
Since joining Danaher in 2017 at Beckman Coulter Diagnostics, where she led commercial operations and R&D before becoming President in 2020, Ms. Sawyer Montgomery has played a central role in transforming Danaher's Diagnostics platform into a market-leading franchise, helping grow the business from approximately $6.0 billion in revenue in 2017 to approximately $11.0 billion today while roughly tripling operating profit. She led Danaher's recent acquisition of Masimo and its pending acquisition of StatLab, and has worked to optimize the Danaher Business System across the Life Sciences and Diagnostics businesses. She brings nearly 25 years of experience across healthcare, commercial operations and R&D.
She has served as Executive Vice President of Danaher since July 2024, after serving as Vice President - Group Executive of Danaher's Diagnostics subsidiary from January 2023 to June 2024 and President of Danaher's Beckman Coulter Diagnostics subsidiary from January 2020 to December 2022.